Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 87

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 87
---
 period in 2024, representing
a decrease of approximately $325,000, or 10%. The reduction primarily reflects management’s continued focus on cost containment
and operational efficiency.

Employee salaries and benefits decreased by approximately $147,000 for
the three months ended September 30, 2025, compared to the same period in 2024, primarily due to workforce realignment and headcount optimization.
In addition, the Company achieved further savings of approximately $178,000 through reductions in marketing, consulting, professional
service fees, insurance, royalties, regulatory, travel, and other general administrative expenses.

These cost reduction measures are part of management’s ongoing initiatives
to streamline operations, align expenses with current revenue levels, and support the Company’s transition toward sustainable profitability

Research
and Development for 2025 and 2024 were as follows:

    2025  
    2024  
    Change 
  
    Dental 
    $15,401  
    $232,056  
    $(216,655)
  
    Medical 
     825  
     -  
     825 
  
    Corporate 
     -  
     -  
     - 
  
    Total research and development 
    $16,226  
    $232,056  
    $(215,830)

Consolidated research and development (R&D) expenses for the three
months ended September 30, 2025, were approximately $16,000, compared to approximately $232,000 for the same period in 2024, representing
a decrease of approximately $216,000, or 93%. The decrease reflects management’s strategic decision to delay development activities
related to the next-generation STA Single Tooth Anesthesia System® instrument.

This temporary reduction in R&D spending allows the Company to focus
financial resources on the commercial expansion of existing products and the continued global rollout of its CompuFlo® and CathCheck®
Systems, while maintaining flexibility to resume development activities at a later date based on market conditions and strategic priorities.

Profit
(Loss) from Operations for 2025 and 2024 were as follows: 

    2025  
    2024  
    Change 
  
    Dental 
    $693,392  
    $678,318  
    $15,074 
  
    Medical 
     (277,011) 
     (333,010) 
     55,999